John Chickosky joined Vala Science’s Board in April 2018 and was elected Executive Chairman in February 2019.
Previously, Mr. Chickosky served as President and Chief Executive Officer of Natrix Separations, Inc., a developer and manufacturer of innovative chromatography technology for biopharmaceutical purification, from 2011 until December 2017. He also served on Natrix’s board of directors from 2010 until December 2017. Before Natrix, Mr. Chickosky held the position of Chief Commercial Officer and President of the BioSystems Division of Xcellerex, Inc., where he was instrumental in developing and executing the company’s commercial strategy until its acquisition by GE Healthcare. Prior to Xcellerex, he held senior positions at Kendro Laboratory Products (now part of ThermoFisher), where he was Vice President, Global Bioprocessing and Drug Discovery Sales and at CARR Separations, where he was Senior Vice President, Sales and Marketing. Prior to CARR, he served as Vice President of Sales and Marketing at AquaAir, Inc. and at Sepracor, Inc as Vice President, Marketing and Vice President, Business Development. He was also a member of the Board of Directors at Bionova Scientific until its acquisition by Asahi Kasei in 2022.
John holds a Bachelor of Science degree in Electrical Engineering and Computer Science from Santa Clara University and an MBA from St. Mary’s College (California).